[Journal logo]

Volume 66 
Part 3 
Page m301  
March 2010  

Received 23 January 2010
Accepted 9 February 2010
Online 13 February 2010

Key indicators
Single-crystal X-ray study
T = 293 K
Mean [sigma](C-C) = 0.003 Å
R = 0.037
wR = 0.112
Data-to-parameter ratio = 21.5
Details
Open access

N-(Ferrocenylmethyl)dodecan-1-amine

aSchool of Chemistry and Chemical Engineering, Shandong University, Jinan 250100, People's Republic of China
Correspondence e-mail: haoay@sdu.edu.cn

The title compound, [Fe(C5H5)(C18H32N)], was synthesized by the amination of ferrocenecarbaldehyde. In the complex, the two cyclopentadienyl (Cp) rings are almost parallel with a dihedral angle of 1.36 (8)°, and are separated by a centroid-centroid distance of 3.299 (2) Å. In the crystal, adjacent molecules are linked into a one-dimensional supramolecular structure via weak C-H...[pi] interactions between the Cp ring H atom and the Cp ring.

Related literature

For the applications of ferrocene in drug design, see: Atteke et al. (2003[Atteke, C., Me Ndong, J. M., Aubouy, A., Maciejewski, L., Brocard, J., Lebibi, J. & Deloron, P. (2003). J. Antimicrob. Chemother. 51, 1021-1024.]); Baramee et al. (2006[Baramee, A., Coppin, A., Mortuaire, M., Pelinski, L., Tomavoc, S. & Brocard, J. (2006). Bioorg. Med. Chem. 14, 1294-1302.]). For linear ferrocene compounds in supramolecular chemisty, see: Zhang et al. (2010[Zhang, H., An, W., Liu, Z., Hao, A., Hao, J., Shen, J., Zhao, X., Sun, H. & Sun, L. (2010). Carbohydr. Res. 345, 87-96.]). For a related structure, see: Zheng & Liu (2009[Zheng, X.-L. & Liu, J.-T. (2009). Acta Cryst. E65, m432.]).

[Scheme 1]

Experimental

Crystal data
  • [Fe(C5H5)(C18H32N)]

  • Mr = 383.39

  • Monoclinic, P 21 /c

  • a = 26.7005 (6) Å

  • b = 8.0549 (2) Å

  • c = 10.0069 (2) Å

  • [beta] = 97.534 (1)°

  • V = 2133.60 (8) Å3

  • Z = 4

  • Mo K[alpha] radiation

  • [mu] = 0.71 mm-1

  • T = 293 K

  • 0.30 × 0.26 × 0.18 mm

Data collection
  • Bruker APEXII CCD diffractometer

  • Absorption correction: multi-scan (SADABS; Sheldrick, 1996[Sheldrick, G. M. (1996). SADABS. University of Göttingen, Germany.]) Tmin = 0.815, Tmax = 0.881

  • 20623 measured reflections

  • 4900 independent reflections

  • 3892 reflections with I > 2[sigma](I)

  • Rint = 0.021

Refinement
  • R[F2 > 2[sigma](F2)] = 0.037

  • wR(F2) = 0.112

  • S = 1.09

  • 4900 reflections

  • 228 parameters

  • H-atom parameters constrained

  • [Delta][rho]max = 0.44 e Å-3

  • [Delta][rho]min = -0.37 e Å-3

Table 1
Selected bond lengths (Å)

C14-Fe1 2.0502 (16)
C15-Fe1 2.0501 (18)
C16-Fe1 2.038 (2)
C17-Fe1 2.0295 (18)
C18-Fe1 2.0398 (18)
C19-Fe1 2.038 (2)
C20-Fe1 2.0350 (17)
C21-Fe1 2.0375 (18)
C22-Fe1 2.0398 (18)
C23-Fe1 2.0347 (19)

Table 2
Hydrogen-bond geometry (Å, °)

Cg1 is the centroid of the C19-C23 ring.

D-H...A D-H H...A D...A D-H...A
C18-H18...Cg1i 0.98 2.96 3.870 (2) 155
Symmetry code: (i) [x, -y+{\script{5\over 2}}, z+{\script{1\over 2}}].

Data collection: APEX2 (Bruker, 2007[Bruker (2007). APEX2 and SAINT-Plus. Bruker AXS Inc., Madison, Wisconsin, USA.]); cell refinement: SAINT-Plus (Bruker, 2007[Bruker (2007). APEX2 and SAINT-Plus. Bruker AXS Inc., Madison, Wisconsin, USA.]); data reduction: SAINT-Plus; program(s) used to solve structure: SIR97 (Altomare et al., 1999[Altomare, A., Burla, M. C., Camalli, M., Cascarano, G. L., Giacovazzo, C., Guagliardi, A., Moliterni, A. G. G., Polidori, G. & Spagna, R. (1999). J. Appl. Cryst. 32, 115-119.]); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); molecular graphics: SHELXTL (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]) and DIAMOND (Brandenburg, 1999[Brandenburg, K. (1999). DIAMOND. Crystal Impact GbR, Bonn, Germany.]); software used to prepare material for publication: WinGX (Farrugia, 1999[Farrugia, L. J. (1999). J. Appl. Cryst. 32, 837-838.]).


Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: HY2280 ).


References

Altomare, A., Burla, M. C., Camalli, M., Cascarano, G. L., Giacovazzo, C., Guagliardi, A., Moliterni, A. G. G., Polidori, G. & Spagna, R. (1999). J. Appl. Cryst. 32, 115-119.  [ISI] [CrossRef] [ChemPort] [details]
Atteke, C., Me Ndong, J. M., Aubouy, A., Maciejewski, L., Brocard, J., Lebibi, J. & Deloron, P. (2003). J. Antimicrob. Chemother. 51, 1021-1024.  [CrossRef] [PubMed] [ChemPort]
Baramee, A., Coppin, A., Mortuaire, M., Pelinski, L., Tomavoc, S. & Brocard, J. (2006). Bioorg. Med. Chem. 14, 1294-1302.  [CrossRef] [PubMed] [ChemPort]
Brandenburg, K. (1999). DIAMOND. Crystal Impact GbR, Bonn, Germany.
Bruker (2007). APEX2 and SAINT-Plus. Bruker AXS Inc., Madison, Wisconsin, USA.
Farrugia, L. J. (1999). J. Appl. Cryst. 32, 837-838.  [CrossRef] [ChemPort] [details]
Sheldrick, G. M. (1996). SADABS. University of Göttingen, Germany.
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.  [CrossRef] [details]
Zhang, H., An, W., Liu, Z., Hao, A., Hao, J., Shen, J., Zhao, X., Sun, H. & Sun, L. (2010). Carbohydr. Res. 345, 87-96.  [ISI] [CrossRef] [PubMed] [ChemPort]
Zheng, X.-L. & Liu, J.-T. (2009). Acta Cryst. E65, m432.  [CSD] [CrossRef] [details]


Acta Cryst (2010). E66, m301  [ doi:10.1107/S1600536810005155 ]

This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.